Tag: CBT > Tilray Cannabis Company: Page 3

Industry Headlines

Tilray Launches ‘Take Back Control’ Platform to Provide Women With Free Medical Cannabis Resources

The new platform also aims to help destigmatize the use of medical cannabis in women’s health care practices.

November 18, 2022

Distribution

Tilray Brands Acquires Montauk Brewing Company

Tilray expands and strengthens its U.S. footprint with acquisition of the fastest growing craft beer brand and top craft brewer in Metro New York.

November 7, 2022

Distribution

Tilray Brands, Charlotte’s Web Announce Strategic Alliance in Canada

Tilray will launch Charlotte’s Web proprietary full-spectrum hemp CBD products across Canada in 2023.

November 2, 2022

Legislation and Regulation

The State of European Cannabis Reform: Fall 2022 Update

Cannabis reform is moving across Europe, but regional uniformity will take a long time.

October 5, 2022

International

Tilray Medical Relaunches Cannabis Oral Solution Across Ireland

Patients in Ireland may now access Tilray’s full-spectrum medical cannabis oil solution through the MCAP.

October 5, 2022

Distribution

Tilray Medical Receives Approval to Extend Market Authorization in Italy

The Italian Ministry of Health has approved Tilray-branded medical cannabis for pharmaceutical distribution.

September 22, 2022

Legislation and Regulation

Tilray Cues German Regulators to Draft Adult-Use Cannabis Legislation

The multinational cannabis company initiated a policy roundtable with regulators to help kickstart legalization efforts in Germany.

September 6, 2022

Canadian Cannabis Market

Good Supply Launches New High-Potency Product Drop and Unveils Exclusive Orange Frost Live Resin

The brand’s latest product drop includes new high-potency concentrates Jean Guy Badder, Hash Bats in Pineapple Express, and Orange Frost Live Resin, available for a limited time.

September 1, 2022

Industry Headlines

Tilray Medical Launches New Products and ‘CannaPoints’ Program to Support Patients Across Canada

Tilray Medical’s latest release of medical cannabis products from differentiated brands includes a comprehensive range of THC and CBD products.

August 25, 2022

International

Tilray Medical Receives Verification From the Natural Health Science Foundation in Australia and New Zealand

A Natural Health Science Foundation assessment further verifies Tilray Medical’s high-quality standard and its CBD100 product for clinical trial use.

August 23, 2022

International

Tilray Medical Bolsters Market Leading Position in Europe With Market Authorization in Poland

The Polish Ministry of Health approved Tilray branded medical cannabis for pharmaceutical distribution in addition to wholesale approval.

August 17, 2022

Finance

Tilray Brands, Inc. Reports Record Fiscal Year 2022 Results

FY2022 Net Revenue Grew 22% to $628 Million Compared to the Prior Year; On a Constant Currency Basis, Net Revenue Increased by 29%.

July 28, 2022